Chen Cheng-Yi, Lin Cheng-Jui, Lin Chih-Sheng, Sun Fang-Ju, Pan Chi-Feng, Chen Han-Hsiang, Wu Chih-Jen
Division of Nephrology, Department of Internal Medicine, Mackay Memorial Hospital, Hsinchu, Taiwan.
MacKay Junior College of Medicine, Nursing and Management, Taipei, Taiwan.
Oncotarget. 2017 Dec 18;9(2):2236-2248. doi: 10.18632/oncotarget.23368. eCollection 2018 Jan 5.
Chronic kidney disease (CKD) in cirrhosis is one of the dreaded complications associated with a steep rise in mortality and morbidity, including diabetes. There are limited data on the prevalence of CKD and the association with diabetes in outpatients with cirrhosis.
This is a cross-sectional study of 7,440 adult liver cirrhosis patients enrolled from August 2001 to April 2010 in a medical center. Case control matching by age and sex with 1,967 pairs, and conditional logistic regression for odds of diabetes was analyzed using adjusted model.
CKD was present in 46.0%, 45.7% and 45.6% of the study population using the MDRD-6, CKD-EPI and MDRD-4 estimated glomerular filtration rate (eGFR) equations, respectively. Using a conditional logistic regression model after adjusting for other risk factors, odds for diabetes increased significantly compared with non-CKD in CKD stage 3 to 5 (stage 35) based on MDRD-6-adjusted model, ORs were: stage 35, 2.34 (95% CI, 1.78-3.01); MDRD-4-adjusted model, ORs were: stage 35, 8.51 (95% CI, 5.63-11.4); CKD-EPI-adjusted model, ORs were: stage 35, 8.61 (95% CI, 5.13-13.9).
In cirrhosis patients, prevalence of diabetes was higher in patients with advanced stage of CKD. For patients with cirrhosis, patients with CKD stages 3~5 defined by MDRD-4, MDRD-6, and CKD-EPI eGFR equations had increased risk for diabetes. More severe cirrhosis, indicated by the Child-Turcott-Pugh classification was also accompanied by an increased risk for diabetes.
肝硬化中的慢性肾脏病(CKD)是一种可怕的并发症,与包括糖尿病在内的死亡率和发病率急剧上升相关。关于肝硬化门诊患者中CKD的患病率及其与糖尿病的关联的数据有限。
这是一项对2001年8月至2010年4月在某医疗中心登记的7440例成年肝硬化患者进行的横断面研究。按年龄和性别进行病例对照匹配,共1967对,并使用调整模型分析糖尿病几率的条件逻辑回归。
分别使用MDRD-6、CKD-EPI和MDRD-4估算肾小球滤过率(eGFR)方程时,研究人群中CKD的患病率分别为46.0%、45.7%和45.6%。在调整其他危险因素后,根据MDRD-6调整模型,在CKD 3至5期(35期)中,与非CKD患者相比,糖尿病几率显著增加,比值比(OR)为:35期,2.34(95%置信区间,1.78 - 3.01);MDRD-4调整模型,OR为:35期,8.51(95%置信区间,5.63 - 11.4);CKD-EPI调整模型,OR为:35期,8.61(95%置信区间,5.13 - 13.9)。
在肝硬化患者中,CKD晚期患者的糖尿病患病率较高。对于肝硬化患者,根据MDRD-4、MDRD-6和CKD-EPI eGFR方程定义的CKD 3~5期患者患糖尿病的风险增加。Child-Turcott-Pugh分类所表明的更严重肝硬化也伴随着糖尿病风险的增加。